SKIP TO MAIN CONTENT

Russian bobsledder Sergeeva tests positive for meldonium

MOSCOW (Reuters) - Russian bobsledder Nadezhda Sergeeva, who competed at the 2014 Sochi Winter Olympics, has tested positive for the banned substance meldonium.

Russian bobsledder Sergeeva tests positive for meldonium
(Reuters)

2 min read

Published

Source: Reuters


Skip to article content

Sergeeva, who finished 16th in the two-person bobsleigh in 2014 with her partner, Nadezhda Paleeva, joins at least 100 other athletes who have recorded positive tests for the drug. The most prominent was the tennis star Maria Sharapova, a five-time grand slam champion.

"I am just shocked about this news, because I am certain that I took this medication only at the end of last year, strictly under the instructions of the doctors from the Federal Medical-Biological Agency as well as cardiologists," the 28-year-old told the R-Sport news agency.

"Of course, both the doctors who prescribed me this substance and I myself were one hundred percent certain that the meldonium would only stay in my system for two or three days and then by 1 January I would be completely clean."

News that makes sense

Your trusted source for staying up-to-date with the world around you. Get free daily news updates and analysis, straight to your inbox.

By subscribing, you agree to SBS’s terms of service and privacy policy including receiving email updates from SBS.

Meldonium was added to the World Anti-Doping Agency's list of banned substances on Jan. 1, 2016. Since then, 100 athletes have been found to have used meldonium, Ben Nichols, WADA's head of communications, said on Tuesday.

At least 11 of them are Russian athletes, including Sharapova, figure skater Ekaterina Bobrova and world champion speed-skater Pavel Kulizhnikov.

Use of meldonium was widespread before its banning. One study showed 490 athletes who competed in last year's European Games in Baku had taken it.

Grindeks, the Latvian company that is the main supplier of the drug, says it could protect athletes from cell damage but was unlikely to improve their performance.

(Reporting By Dmitriy Rogovitskiy, editing by Larry King)


Get SBS News straight to your inbox

Sign up now for daily news from Australia and around the world. You can also subscribe to Insight's weekly newsletter for in-depth features and first-person stories.

By subscribing, you agree to SBS’s terms of service and privacy policy including receiving email updates from SBS.

Follow SBS News

Download our apps

Listen to our podcasts

Get the latest with our News podcasts on your favourite podcast apps.

Watch on SBS

SBS World News

Take a global view with Australia's most comprehensive world news service

Stream now

Watch the latest news videos from Australia and across the world